The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A clinical trial evaluating the efficacy and safety of disitamab vedotin plus tislelizumab combined with re-TURBT in the treatment of HER-2-high expression (2+-3+) non-muscle invasive bladder cancer at high-risk and very high-risk.
 
Jianhui Chen
No Relationships to Disclose
 
Yiming Su
No Relationships to Disclose
 
Rong Liu
No Relationships to Disclose
 
Ru Chen
No Relationships to Disclose
 
Shaoxing Zhu
No Relationships to Disclose
 
Qianyi Qiu
No Relationships to Disclose